(Total Views: 608)
Posted On: 03/23/2022 1:50:59 PM
Post# of 156319
Hulk
I agree that it is a bit off that a real pharma company has not made an offer yet for any indication in any market.
We have heard that they have been looking at the data yet still no public offers.
Our two deals in the US were Vyera for HIV ( since sold off to another even as smaller firm) and American Regent to distribute for COVID - since terminated.
Still expect a partnership buy wonder why nothing yet.
IMO
I agree that it is a bit off that a real pharma company has not made an offer yet for any indication in any market.
We have heard that they have been looking at the data yet still no public offers.
Our two deals in the US were Vyera for HIV ( since sold off to another even as smaller firm) and American Regent to distribute for COVID - since terminated.
Still expect a partnership buy wonder why nothing yet.
IMO
(0)
(0)
